Divis Laboratories Ltd. | DIVISLAB | NSE - Pharmaceuticals


INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.

 Chart
2019
2020
2021
2022
2023
Revenue
Revenue
49,46353,94470,32090,73781,122
Cost of revenue
Cost of revenue
-18,252-21,085-23,241-29,671-30,537
Gross Profit
Gross Profit
31,210
32,859
47,079
61,066
50,585
Sales, general & ad...
Sales, general and administrative
-12,492-14,637-17,854-21,108-23,460
Depreciation
Depreciation and amortization
-1,689-1,862-2,556-3,115-3,432
Provision
Provision
00000
Other op inc/exp...
Other operating income/expenses
00000
Operating income
Operating income EBIT
17,029
16,359
26,669
36,843
23,693
 
      
Profit before tax
Profit before tax
18,55118,19526,66036,83523,686
Net Income
Net income
13,527
13,765
19,843
29,605
18,234
 
 
 
 
 
 
 
EPS Basic
EPS Basic in Rupees
50.96
51.85
74.73
111.52
68.69